30
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
5819813
551854
1
Public Timelines
FAQ
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Open cabinet
For educational institutions
For teachers
For students
Open cabinet
Creare
Close
Create a timeline
Public timelines
Library
FAQ
21 lugl 2020 anni - AstraZeneca’s Phase I/II clinical trial for AZD1222 demonstrated a robust immune response (neutralizing antibody levels).
Aggiunto al nastro di tempo:
COVID 2020 - Policy, vaccines, therapies, and testing
By
MedicalGold.ca
16 set 2021
0
0
557
Data:
21 lugl 2020 anni
Adesso
~ 3 years and 9 months ago
About & Feedback
Accordo
Privatezza
Biblioteca
2024
©
Time.Graphics
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on
Trustpilot.com
